Quality of Life in HIV-Infected Patients in Penitentiary Institutions

Authors

  • N.R. Abdullayeva Azerbaijan Medical University, Department of Neurology, Baku, Azerbaijan

DOI:

https://doi.org/10.61788/njn.v1i25.03

Keywords:

prison, HIV, depression, anxiety, quality of life, neurocognitive disorder

Abstract

Background. Prisoners have a lower quality of life compared to the general population. The decline in their quality of life may be due to unfavorable social and demographic factors, as well as a number of physical and mental health problems, in particular human immunodeficiency virus. Purpose of the work. The purpose of this study was to assess the quality of life of infected persons with human immunodeficiency virus in penitentiary institutions of Azerbaijan and their relationship with various indicators. Material and methods. The study was conducted in penitentiary institutions of Azerbaijan among prisoners meeting the inclusion criteria, a cross-sectional design was used. The study was approved by the Ethics Committee of the Azerbaijan Medical University (P.23/19.05.2022). Demographic and clinical data including age, gender, course of human immunodeficiency virus infection, antiretroviral therapy, drug use and length of incarceration were collected using a structured questionnaire. Standardized assessment methods were used, including the Hospital Anxiety and Depression Scale and the Mini Mental Test to assess neurocognitive performance. The quality of life of patients was assessed using the SF 36 questionnaire.The obtained quantitative and qualitative data were statistically processed using medical statistics methods. Results. The average score for the “physical health” domain of quality of life was 55.2 points, and the average score for the “mental health” domain was 52.8. Subjects with HIV-associated dementia had the lowest quality of life scores in the categories of “physical functioning” (p=0.05), “mental health” (p<0.001), “body pain” (p<0.001), “vitality” (p=0.001) and “general health” (p=0.001) compared with those with asymptomatic and mild neurocognitive disorders. The lowest scores in all areas of quality of life were observed in patients with severe depression and severe anxiety (p<0.001). At the same time, the subjects who were not diagnosed with either anxiety or depressive disorders showed the highest scores when assessing quality of life (p<0.001). Conclusion. Low quality of life was associated with the presence of varying degrees of depression, anxiety disorders, and cognitive impairment (p<0.001). At the same time, the age of the patients, gender, education, years of imprisonment, antiretroviral therapy did not affect the quality of life. The results of this study will help assess the overall quality of life of human immunodeficiency virus positive prisoners, identifying possible connections with various aspects of the disease itself and its neurological complications.

References

Alford K, Daley S, Banerjee S, Hamlyn E, et al. "A fog that impacts everything": a qualitative study of health-related quality of life in people living with HIV who have cognitive impairment // Qual Life Res. 2022 Oct;31(10):3019-3030. doi: 10.1007/s11136-022-03150-x.

Alford K, Daley S, Banerjee S, Vera JH. Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study // PLoS One. 2021 May 19;16(5):e0251944. doi: 10.1371/journal.pone.0251944.

Antinori A, Arendt G, Becker JT, Brew BJ, et al. Updated research nosology for HIV-associated neurocognitive disorders // Neurology, 2007;69:1789-1799.

Arbuckle J.IBM SPSS Amos 21: Users Guide IBM Corp., Amos Development Corporation, 2012, 680 p.

Board. UPC, editor Thematic Segment: Mental health and HIV/AIDS—promoting human rights, an intergrated and person-centred approach to improving ART adherence, well-being and quality of life. Joint United Nations Programme on HIV/AIDS; 2018; Geneva.

Burrows, Dave Boltaev, Azizbek MusaMirza; Gottfreðsson Magnús; Suleymanova Javahir Review of the HIV programme in Azerbaijan: November 2014. Copenhagen; World Health Organization. Regional Office for Europe; 2016. (WHO/EURO:2016-6486-46252-66903).WHO IRIS | ID: who-369413

Dal-Bo MJ, Manoel AL, Filho AO, Silva BQ, Cardoso YS, Cortez J, et al. Depressive Symptoms and Associated Factors among People Living with HIV/AIDS // Journal of the International Association of Providers of AIDS Care. 2015;14(2):136-140.

Dolan K, Wirtz AL, Moazen B, Ndefo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees // The Lancet. 2016;388(10049):1089-102.

Engelhard EAN, Smit C, van Dijk PR, Kuijper TM, Wermeling PR, Weel AE, et al. Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases // AIDS. 2018;32(1):103-12. 10.1097/QAD. 0000000000001672

Ghisvand H, Higgs P, Noroozi M, Harouni GG, Hemmat M, Ahounbar E, et al. Social and demographic determinants of quality of life in people who live with HIV/AIDS infection: evidence from a meta-analysis // Biodemography and Social Biology. 2019:1-16.

Golrokhi R, Farhoudi B, Taj L, Pahlaviani FG, Mazaheri-Tehrani E, Cossarizza A, et al. HIV prevalence and correlations in prisons in different regions of the world: a review article // Open AIDS J. 2018;12:81.

Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993 Oct;2(3):217-27. doi: 10.1002/hec.4730020305.

HIV.gov. Overview: Data & Trends: Global Statistics https://www.hiv.gov/hiv-basics/ overview/data-and-trends/global-statistics2020.

Korenromp EL, Williams BG, Schmid GP, Dye C. Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection - a quantitative review // PLoS One, 2009;4(6):e5950.

Lazarus JV, Safreed-Harmon K, Barton SE, Costagliola D, Dedes N, Del Amo Valero J, et al. Beyond viral suppression of HIV - the new quality of life frontier // BMC Med. 2016;14(1):94. 10.1186/s12916-016-0640-4

Mehdiyev R, Alikhanova N, Gurbanova E. HIV/tuberculosis/hepatitis C virus services for incarcerated populations in Azerbaijan and the Eastern Europe Central Asia region // Curr Opin HIV AIDS. 2019 Jan;14(1):66-70. doi:10.1097/COH.0000000000000513.

Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, et al. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population // Lancet HIV. 2014;1(1):e32-40. Doi: 10.1016/S2352-3018(14)70018-9

Moazen B, Saeedi Moghaddam S, Silbernagl MA, Lotfzadeh M, Bosworth RJ, Alammehrjerdi Z, et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates // Epidemiol Rev. 2018;40(1):58-69.

Nachega JB, Morroni C, Zuniga JM, Sherer R, Beyrer C, Solomon S, et al. HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults // Journal of the International Association of Physicians in AIDS Care (Chicago, Ill: 2002), 2012;11(3):172-178

Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis // BMJ Support Palliat Care. 2019 Dec;9(4):404-412. doi: 10.1136/bmjspcare-2019-001952.

Ruiz-Pérez I, Olry de Labry-Lima A, López-Ruz MA, et al. Clinical status, adherence to HAART and quality of life in HIV-infected patients receiving antiretroviral treatment // Enferm Infecc Microbiol Clin.,2005;23(10):581-585.

Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review // AIDS. 2011 Mar 13;25(5):561-75. doi: 10.1097/QAD.0b013e3283437f9a. PMID: 21160410.

Shrestha R, Weikum D, Copenhaver M, Altice FL. The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis // AIDS and Behavior.2016:1-12.

Smith HJ, Topp SM, Hoffmann CJ, Ndlovu T, et al. Addressing Common Mental Health Disorders Among Incarcerated People Living with HIV: Insights from Implementation Science for Service Integration and Delivery // Curr HIV/AIDS Rep. 2020 Oct;17(5):438-449. doi: 10.1007/s11904-020-00518-x.

Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, et al. Neurocognitive performance and quality of life in patients with HIV infection // AIDS Res Hum Retroviruses. 2003;19(8):643-52. 10.1089/088922203322280856.

Valera P, Chang Y, Lian Z. HIV risk inside US prisons: a systematic review of risk reduction interventions conducted in US prisons // AIDS Care. 2017;29(8):943-52.

Yousuf A, Mohd Arifin SR, Musa R, Md Isa ML. Depression and HIV Disease Progression: A Mini-Review // Clin Pract Epidemiol Ment Health, 2019; 31;15:153-159. doi: 10.2174/ 1745017901915010153.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale // Acta Psychiatr Scand 67:361-370.

Downloads

Published

30.06.2024

How to Cite

Abdullayeva, N. (2024). Quality of Life in HIV-Infected Patients in Penitentiary Institutions. National Journal of Neurology, 23–31. https://doi.org/10.61788/njn.v1i25.03

Issue

Section

Original Articles